| Year |
Citation |
Score |
| 2023 |
Resop RS, Salvatore B, Kim SJ, Gordon BR, Blom B, Vatakis DN, Uittenbogaart CH. HIV-1 Infection Results in Sphingosine-1-Phosphate Receptor 1 Dysregulation in the Human Thymus. International Journal of Molecular Sciences. 24. PMID 37762169 DOI: 10.3390/ijms241813865 |
0.377 |
|
| 2019 |
Vatakis D. Engineering hematopoietic stem cells to create melanoma specific CTL. Oncoimmunology. 1: 539-540. PMID 22754779 DOI: 10.4161/Onci.19408 |
0.39 |
|
| 2018 |
Quach A, Horvath S, Nemanim N, Vatakis D, Witt MD, Miller EN, Detels R, Langfelder P, Shapshak P, Singer EJ, Levine AJ. No reliable gene expression biomarkers of current or impending neurocognitive impairment in peripheral blood monocytes of persons living with HIV. Journal of Neurovirology. PMID 29582356 DOI: 10.1007/S13365-018-0625-5 |
0.366 |
|
| 2016 |
Saleh S, Lu HK, Evans V, Harisson D, Zhou J, Jaworowski A, Sallmann G, Cheong KY, Mota TM, Tennakoon S, Angelovich TA, Anderson J, Harman A, Cunningham A, Gray L, ... ... Vatakis DN, et al. HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB. Retrovirology. 13: 49. PMID 27459960 DOI: 10.1186/S12977-016-0284-7 |
0.485 |
|
| 2015 |
Kim SG, Lowe EL, Dixit D, Seyeon Youn C, Kim IJ, Jung JB, Rovner R, Zack JA, Vatakis DN. Cocaine-mediated impact on HIV infection in humanized BLT mice. Scientific Reports. 5: 10010. PMID 26084721 DOI: 10.1038/Srep10010 |
0.398 |
|
| 2015 |
Burke BP, Levin BR, Zhang J, Sahakyan A, Boyer J, Carroll MV, Colón JC, Keech N, Rezek V, Bristol G, Eggers E, Cortado R, Boyd MP, Impey H, Shimizu S, ... ... Vatakis DN, et al. Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector. Molecular Therapy. Nucleic Acids. 4: e236. PMID 25872029 DOI: 10.1038/Mtna.2015.10 |
0.453 |
|
| 2015 |
McCracken MN, Vatakis DN, Dixit D, McLaughlin J, Zack JA, Witte ON. Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging. The Journal of Clinical Investigation. 125: 1815-26. PMID 25822024 DOI: 10.1172/Jci77326 |
0.402 |
|
| 2013 |
Nixon CC, Vatakis DN, Reichelderfer SN, Dixit D, Kim SG, Uittenbogaart CH, Zack JA. HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice. Blood. 122: 2195-204. PMID 23886835 DOI: 10.1182/Blood-2013-04-496950 |
0.419 |
|
| 2013 |
Kim SG, Jung JB, Dixit D, Rovner R, Zack JA, Baldwin GC, Vatakis DN. Cocaine exposure enhances permissiveness of quiescent T cells to HIV infection. Journal of Leukocyte Biology. 94: 835-43. PMID 23817564 DOI: 10.1189/Jlb.1112566 |
0.471 |
|
| 2013 |
Zack JA, Kim SG, Vatakis DN. HIV restriction in quiescent CD4⁺ T cells. Retrovirology. 10: 37. PMID 23557201 DOI: 10.1186/1742-4690-10-37 |
0.498 |
|
| 2013 |
Vatakis DN, Arumugam B, Kim SG, Bristol G, Yang O, Zack JA. Introduction of exogenous T-cell receptors into human hematopoietic progenitors results in exclusion of endogenous T-cell receptor expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1055-63. PMID 23481324 DOI: 10.1038/Mt.2013.28 |
0.434 |
|
| 2012 |
Vatakis DN, Bristol GC, Kim SG, Levin B, Liu W, Radu CG, Kitchen SG, Zack JA. Using the BLT humanized mouse as a stem cell based gene therapy tumor model. Journal of Visualized Experiments : Jove. e4181. PMID 23271478 DOI: 10.3791/4181 |
0.4 |
|
| 2011 |
Vatakis DN, Koya RC, Nixon CC, Wei L, Kim SG, Avancena P, Bristol G, Baltimore D, Kohn DB, Ribas A, Radu CG, Galic Z, Zack JA. Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 108: E1408-16. PMID 22123951 DOI: 10.1073/Pnas.1115050108 |
0.442 |
|
| 2011 |
Marban C, Su T, Ferrari R, Li B, Vatakis D, Pellegrini M, Zack JA, Rohr O, Kurdistani SK. Genome-wide binding map of the HIV-1 Tat protein to the human genome. Plos One. 6: e26894. PMID 22073215 DOI: 10.1371/Journal.Pone.0026894 |
0.371 |
|
| 2011 |
Vatakis D, McMillan M. The signal peptide sequence impacts the immune response elicited by a DNA epitope vaccine. Clinical and Vaccine Immunology : Cvi. 18: 1776-80. PMID 21832097 DOI: 10.1128/Cvi.05179-11 |
0.531 |
|
| 2010 |
Vatakis DN, Nixon CC, Zack JA. Quiescent T cells and HIV: an unresolved relationship. Immunologic Research. 48: 110-21. PMID 20725862 DOI: 10.1007/S12026-010-8171-0 |
0.519 |
|
| 2009 |
Vatakis DN, Kim S, Kim N, Chow SA, Zack JA. Human immunodeficiency virus integration efficiency and site selection in quiescent CD4+ T cells. Journal of Virology. 83: 6222-33. PMID 19369341 DOI: 10.1128/Jvi.00356-09 |
0.473 |
|
| 2009 |
Vatakis DN, Nixon CC, Bristol G, Zack JA. Differentially stimulated CD4+ T cells display altered human immunodeficiency virus infection kinetics: implications for the efficacy of antiviral agents. Journal of Virology. 83: 3374-8. PMID 19129455 DOI: 10.1128/Jvi.02161-08 |
0.455 |
|
| 2008 |
Gelderblom HC, Vatakis DN, Burke SA, Lawrie SD, Bristol GC, Levy DN. Viral complementation allows HIV-1 replication without integration. Retrovirology. 5: 60. PMID 18613957 DOI: 10.1186/1742-4690-5-60 |
0.44 |
|
| 2007 |
Burke B, Brown HJ, Marsden MD, Bristol G, Vatakis DN, Zack JA. Primary cell model for activation-inducible human immunodeficiency virus. Journal of Virology. 81: 7424-34. PMID 17475639 DOI: 10.1128/Jvi.02838-06 |
0.474 |
|
| 2007 |
Vatakis DN, Bristol G, Wilkinson TA, Chow SA, Zack JA. Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells. Journal of Virology. 81: 3574-82. PMID 17229711 DOI: 10.1128/Jvi.02569-06 |
0.493 |
|
| 2006 |
Arlen PA, Brooks DG, Gao LY, Vatakis D, Brown HJ, Zack JA. Rapid expression of human immunodeficiency virus following activation of latently infected cells. Journal of Virology. 80: 1599-603. PMID 16415036 DOI: 10.1128/Jvi.80.3.1599-1603.2006 |
0.362 |
|
| 2005 |
Vatakis DN, Koh YT, McMillan M. CD4+ T cell epitope affinity to MHC II influences the magnitude of CTL responses elicited by DNA epitope vaccines. Vaccine. 23: 2639-46. PMID 15780447 DOI: 10.1016/J.Vaccine.2004.10.039 |
0.597 |
|
| Show low-probability matches. |